PortfoliosLab logoPortfoliosLab logo
OVID vs. ARAAF
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OVID vs. ARAAF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ovid Therapeutics Inc. (OVID) and Aclara Resources Inc (ARAAF). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OVID achieves a 36.20% return, which is significantly lower than ARAAF's 60.18% return.


OVID

1D
-6.33%
1M
-17.47%
6M
42.31%
YTD
36.20%
1Y
344.00%
3Y*
-14.61%
5Y*
-9.86%
10Y*
ALL TIME*
-18.07%

ARAAF

1D
0.40%
1M
-10.60%
6M
-4.89%
YTD
60.18%
1Y
175.15%
3Y*
97.28%
5Y*
10Y*
ALL TIME*
18.38%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$160.52K$201.49K$247.19K
$3.75M$4.12M$6.04M

OVID vs. ARAAF - Yearly Performance Comparison


2026 (YTD)20252024202320222021
OVID
Ovid Therapeutics Inc.
36.20%74.57%-71.00%73.12%-42.06%-0.62%
ARAAF
Aclara Resources Inc
60.18%404.63%-11.58%49.59%-78.68%-4.89%

Correlation

The correlation between OVID and ARAAF is 0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.03

Correlation (3Y)
Balances recent behavior with more history.

0.04

Correlation (All Time)
Calculated using the full available price history since Dec 29, 2021

0.05

Fundamentals

Market Cap

OVID:

$414.34M

ARAAF:

$613.37M

EPS

OVID:

-$0.25

ARAAF:

-$0.05

PB Ratio

OVID:

1.52

ARAAF:

3.68

Total Revenue (TTM)

OVID:

$7.12M

ARAAF:

$0.00

Gross Profit (TTM)

OVID:

$7.06M

ARAAF:

-$1.03M

EBITDA (TTM)

OVID:

-$47.25M

ARAAF:

-$9.35M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Ovid Therapeutics Inc.

Aclara Resources Inc

Return for Risk

OVID vs. ARAAF — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

OVID
OVID Risk / Return Rank: 9797
Overall Rank
OVID Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
OVID Sortino Ratio Rank: 9797
Sortino Ratio Rank
OVID Omega Ratio Rank: 9595
Omega Ratio Rank
OVID Calmar Ratio Rank: 9999
Calmar Ratio Rank
OVID Martin Ratio Rank: 9898
Martin Ratio Rank

ARAAF
ARAAF Risk / Return Rank: 8686
Overall Rank
ARAAF Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
ARAAF Sortino Ratio Rank: 8989
Sortino Ratio Rank
ARAAF Omega Ratio Rank: 8484
Omega Ratio Rank
ARAAF Calmar Ratio Rank: 8787
Calmar Ratio Rank
ARAAF Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

OVID vs. ARAAF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ovid Therapeutics Inc. (OVID) and Aclara Resources Inc (ARAAF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


OVIDARAAFDifference
Sharpe ratioReturn per unit of total volatility

+1.70

Sortino ratioReturn per unit of downside risk

+1.23

Omega ratioGain probability vs. loss probability

1.46

1.30

+0.16

Calmar ratioReturn relative to maximum drawdown

9.97

3.04

+6.92

Martin ratioReturn relative to average drawdown

24.15

5.94

+18.22

OVID vs. ARAAF - Sharpe Ratio Comparison

The current OVID Sharpe Ratio is 3.30, which is higher than the ARAAF Sharpe Ratio of 1.60. The chart below compares the historical Sharpe Ratios of OVID and ARAAF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

OVID vs. ARAAF - Drawdown Comparison

The maximum OVID drawdown since its inception was -98.30%, which is greater than ARAAF's maximum drawdown of -84.58%. Use the drawdown chart below to compare losses from any high point for OVID and ARAAF.


Loading charts...

Drawdown Indicators


OVIDARAAFDifference

Max Drawdown

Largest peak-to-trough decline

-98.30%

-84.58%

-13.72%

Max Drawdown (1Y)

Largest decline over 1 year

-34.78%

-56.89%

+22.11%

Max Drawdown (3Y)

Largest decline over 3 years

-93.69%

-56.89%

-36.80%

Max Drawdown (5Y)

Largest decline over 5 years

-93.69%

Current Drawdown

Current decline from peak

-85.20%

-33.77%

-51.43%

Average Drawdown

Average peak-to-trough decline

-75.24%

-57.21%

-18.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.32%

29.10%

-14.78%

Volatility

OVID vs. ARAAF - Volatility Comparison

Ovid Therapeutics Inc. (OVID) and Aclara Resources Inc (ARAAF) have volatilities of 14.68% and 14.42%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OVIDARAAFDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.68%

14.42%

+0.26%

Volatility (6M)

Calculated over the trailing 6-month period

49.53%

54.42%

-4.89%

Volatility (1Y)

Calculated over the trailing 1-year period

105.07%

108.64%

-3.57%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

80.36%

117.17%

-36.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.39%

117.17%

-31.78%

Dividends

OVID vs. ARAAF - Dividend Comparison

Neither OVID nor ARAAF has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

OVID vs. ARAAF - Financials Comparison

This section allows you to compare key financial metrics between Ovid Therapeutics Inc. and Aclara Resources Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


OVID and ARAAF have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OVID has higher volatility (14.68%) compared to ARAAF (14.42%). In terms of maximum drawdown, OVID dropped -98.30% vs ARAAF's -84.58%.

OVID currently has the higher Sharpe Ratio (3.30 vs 1.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OVID and ARAAF

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer